about
Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.Peripheral muscle dysfunction in COPD: lower limbs versus upper limbs.Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients.Upper and lower limb muscles in patients with COPD: similarities in muscle efficiency but differences in fatigue resistance.A symptom-limited incremental step test determines maximum physiological responses in patients with chronic obstructive pulmonary disease.Alternative strategies for exercise critical power estimation in patients with COPD.Clinical role of rapid-incremental tests in the evaluation of exercise-induced bronchoconstriction.Impact of biological therapy on body composition of patients with Chron's disease.Chest wall mobility is related to respiratory muscle strength and lung volumes in healthy subjects.Scaling skeletal muscle function to mass in patients with moderate-to-severe COPDA step test to assess exercise-related oxygen desaturation in interstitial lung diseaseSkeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patientsRelationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional statusComparison of cardiopulmonary responses during 2 incremental step tests in subjects with COPDChester step test in patients with COPD: reliability and correlation with pulmonary function test resultsPressure response after resistance exercise for different body segments in hypertensive peopleTHE INFLAMMATORY BOWEL DISEASE-FATIGUE PATIENT SELF-ASSESSMENT SCALE: TRANSLATION, CROSS-CULTURAL ADAPTATION AND PSYCHOMETRIC PROPERTIES OF THE BRAZILIAN VERSION (IBD-F BRAZIL)PHYSICAL ACTIVITY IN DAILY LIFE, EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE ON INFLIXIMAB-INDUCED REMISSION: A PRELIMINARY STUDY
P50
Q35091104-06CDEE92-AE63-44B6-93D1-4328670608CCQ37900865-5B5CF2A2-CD07-4E31-8C11-34EFE600C47DQ38992317-58FEAF73-A936-4015-A769-C0068A67A676Q43536314-BEF87335-5314-4CD7-B416-452C31429108Q43859240-098163B4-24D8-44CB-AC5A-42867F55A80FQ47702567-5F86FBBA-AED2-436B-8139-C8F96712A994Q47706638-05742426-F644-4E29-A593-EC4200FF3986Q50525563-3A9A2DD0-014F-42AE-9408-E284C1D76B41Q51217491-78D59C26-F4F6-426A-BA05-29BBA0F37F44Q79190388-FF5FB28E-774E-474F-B01A-C8A8072F3884Q79271310-8F0DB0C0-9249-4647-AF75-6EC3AD71DA5CQ79437742-709BB890-739D-4DB6-8126-BFEB3BD23556Q83854141-E5F79839-E9D2-4E18-903F-232C60BA1965Q84401422-B09F35D5-83DC-4494-AE99-FE5409E7832BQ84526804-D7032F4F-769C-41C8-84C6-91699406ADFDQ84965354-DB262D84-695E-4EC6-BF4F-B29D4B65DC17Q90039670-FBFB8CCE-BE4E-478C-A5CF-2AE135D43457Q90746345-9019B80F-98CD-4F1E-8283-C6373393DCE3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carla Malaguti
@ast
Carla Malaguti
@en
Carla Malaguti
@es
Carla Malaguti
@nl
Carla Malaguti
@sl
type
label
Carla Malaguti
@ast
Carla Malaguti
@en
Carla Malaguti
@es
Carla Malaguti
@nl
Carla Malaguti
@sl
prefLabel
Carla Malaguti
@ast
Carla Malaguti
@en
Carla Malaguti
@es
Carla Malaguti
@nl
Carla Malaguti
@sl
P1053
G-4049-2013
P106
P1153
6603834285
P21
P31
P3829
P496
0000-0002-6619-136X